Zidovudine: all 219 studies that test it

Page 1 of 3. Open to participants first (1), then studies with results posted, then the rest; newest registration first within each.

• Natural History Study of the KSHV Inflammatory Cytokine Syndrome (KICS)RecruitingNCT01419561Phase 2
• Belinostat Therapy With Zidovudine for Adult T-Cell Leukemia-LymphomaCompletedNCT02737046Phase 2Results posted
• Chemotherapy for Relapsed Epstein Barr Virus Associated LymphomaTerminatedNCT01964755Phase 2Results posted
• IMPAACT P1092: Steady State PK in Malnourished HIV Infected ChildrenCompletedNCT01818258Phase 4Results posted
• Evaluating the Response to Two Antiretroviral Medication Regimens in HIV-Infected Pregnant Women, Who Begin Antiretroviral Therapy Between 20 and 36 Weeks of Pregnancy, for the Prevention of Mother-to-Child TransmissionCompletedNCT01618305Phase 4Results posted
• Effect of Gender and HIV Infection on Zidovudine and Lamivudine PharmacokineticsCompletedNCT01386970Phase 4Results posted
• Study of Options for Second-Line Effective Combination Therapy (SELECT)CompletedNCT01352715Phase 3Results posted
• Determining the Effects of Observed and Self-Administered Drug Regimens in HIV Infected AdultsCompletedNCT00608569Not applicableResults posted
• Optimizing Pediatric HIV-1 Treatment in Infants With Prophylactic Exposure to Nevirapine, Nairobi, KenyaTerminatedNCT00427297Phase 3Results posted
• Antiretroviral Therapy for Advanced HIV Disease in South AfricaCompletedNCT00342355Phase 4Results posted
• ALTAIR - Alternative Antiretroviral Strategies : a Comparison of Three Initial RegimensCompletedNCT00335322Phase 4Results posted
• Trizivir Vs. Kaletra and Combivir for the Prevention of Mother-to-Child Transmission of HIVCompletedNCT00270296Phase 2Results posted
• Anti-HIV Drugs for Treating Infants Who Acquired HIV Infection at BirthCompletedNCT00102960Phase 3Results posted
• Comparison of Three Anti-HIV Regimens to Prevent Nevirapine Resistance in Women Who Take Nevirapine During PregnancyCompletedNCT00099632Phase 2Results posted
• Trial of Three Neonatal Antiretroviral Regimens for Prevention of Intrapartum HIV TransmissionCompletedNCT00099359Phase 3Results posted
• Trial of Maraviroc (UK-427,857) in Combination With Zidovudine/Lamivudine Versus Efavirenz in Combination With Zidovudine/LamivudineCompletedNCT00098293Phase 3Results posted
• Prospective Evaluation of Anti-retroviral Combinations for Treatment Naive, HIV Infected Persons in Resource-limited SettingsCompletedNCT00084136Phase 4Results posted
• Preventing Sexual Transmission of HIV With Anti-HIV DrugsCompletedNCT00074581Phase 3Results posted
• Inhibition of Reverse Transcription in Aicardi-Goutières SyndromeCompletedNCT04731103Phase 2
• Nucleosides And Darunavir/Dolutegravir In AfricaStatus unknownNCT03988452Phase 3
• Latency and Early Neonatal Provision of Antiretroviral Drugs Clinical TrialCompletedNCT02431975Phase 4
• Early Infant HIV Treatment in BotswanaActive, not recruitingNCT02369406Phase 2/3
• Tipranavir Dose-response Study Using a Prototype Self-emulsifying Drug Delivery System (SEDDS) Formulation in Treatment-naive HIV-1 Infected Patients Report on the Post-study Option, a Treatment of Triple Therapy With Delavirdine, ZDV and 3TC Without TipranavirCompletedNCT02249130Phase 2
• Nevirapine vs Ritonavir-boosted Lopinavir in ART Naive HIV-infected Adults in a Resource Limited SettingCompletedNCT01772940Phase 4
• Economic, Clinical and Quality of Life Assessment in Patients on Antiretroviral TherapyCompletedNCT01694017Phase 4
• The Mochudi Prevention Project ART ProtocolTerminatedNCT01583439Not applicable
• Safety of Reduced Dose Zidovudine (AZT) Compared With Standard Dose AZT in Antiretroviral-naïve HIV-infected PatientsStatus unknownNCT01540240Phase 2/3
• Perinatal Antiretroviral Intensification for PMTCT of HIV in Late ComersCompletedNCT01511237Phase 3
• Bioequivalence Study of Pediatric Formulations to Treat HIV InfectionStatus unknownNCT01469520Phase 1
• Clinical Study of an Aluvia-based HAART Regimen for Prevention of Mother-to-child HIV Transmission in AfricaCompletedNCT01088516Phase 4
• CD4 Cell Recovery in HIV-1 Patients Comparing 2 Treatment RegimesCompletedNCT00966160Phase 3
• A Pilot Study Of the Effects of Highly Active Antiretroviral Therapy on Kaposi's Sarcoma in ZimbabweCompletedNCT00834457Phase 2/3
• Bioequivalence Study of Zidovudine 300 mg Tablets, USP Under Fed ConditionsCompletedNCT00779376Not applicable
• Bioequivalence Study of Zidovudine 300 mg Tablets, USP Under Fasting ConditionsCompletedNCT00779233Not applicable
• Differences in Malaria Infection Levels in HIV-infected Infants and Children Receiving PI- and NNRTI-based HAARTCompletedNCT00719602Early Phase 1
• Safety and Pharmacokinetic Study of Fixed Dose Combination of Zidovudine, Lamivudine, and Nevirapine in HIV-Infected Children in ThailandCompletedNCT00672412Phase 1/2
• A 72-week Randomized Clinical Trial Comparing the Safety and Efficacy of Three Initial Antiretroviral Regimens -GPO-VIR S (d4T/3TC/NVP) for 24 Weeks Followed by GPO-VIR Z (AZT/3TC/NVP) vs GPO-VIR Z vs TDF/FTC/NVPCompletedNCT00669487Phase 3
• Three Generic Nevirapine-Based Antiretroviral Treatments in Chinese Patients:Multicentric Observation CohortCompletedNCT00618176Phase 4
• Bioequivalency Study of Zidovudine Under Fasting ConditionsCompletedNCT00602550Not applicable
• Bioequivalency Study of Zidovudine Under Fed ConditionsCompletedNCT00601562Not applicable
• Safety, Tolerance, Pharmacokinetic and Antiviral Study of Amdoxovir in Combination With Zidovudine in Adults With HIVCompletedNCT00432016Phase 1/2
• Zidovudine Plus Lamivudine in HTLV-I-associated Myelopathy: a Randomised TrialCompletedNCT00272480Phase 2/3
• Efficacy and Safety of Kaletra Monotheraphy Compared to Kaletra Based Triple Therapy to Treat HIV in Antiretroviral Naїve PatientsCompletedNCT00234923Phase 3
• When to Start Anti-HIV Drugs in Children Infected With HIV (The PREDICT Study)CompletedNCT00234091Phase 3
• Bortezomib and Antiviral Therapy Followed By Effusion Drainage, Bevacizumab, and Combination Chemotherapy in Treating Patients With Primary Effusion LymphomaCompletedNCT00217503Phase 2
• A Pilot Study of Triple NtRTI/NsRTI Therapy in Antiretroviral Naive HIV-1 Infected PatientsStatus unknownNCT00199121Phase 4
• NRTI-Sparing Pilot StudyCompletedNCT00143689Phase 4
• One Month Dual Antiretroviral Prophylaxis to Prevent Resistance Mutations in Mothers Exposed to Single Dose NevirapineCompletedNCT00142337Phase 2
• Early Versus Standard Start of Anti-HIV Therapy for Treatment-Naive Adults in HaitiCompletedNCT00120510Not applicable
• Extended Infant Post-exposure Prophylaxis With Antiretrovirals to Reduce Postnatal HIV TransmissionCompletedNCT00115648Phase 3
• Efavirenz and Lamivudine/Zidovudine for Treatment-Naive HIV Infected People in Wenxi County, Shanxi Province, ChinaCompletedNCT00100594Not applicable
• Efavirenz and Lamivudine/Zidovudine for Treatment-Naive HIV Infected Adults in SenegalCompletedNCT00100568Not applicable
• Virotherapy and Natural History Study of KHSV-Associated Multricentric Castleman s Disease With Correlates of Disease ActivityActive, not recruitingNCT00092222Phase 2
• Comparison of Anti-HIV Drug Combinations to Prevent Mother-to-Child Transmission of HIVCompletedNCT00086359Phase 3
• Lopinavir/Ritonavir in Combination With Saquinavir Mesylate or Lamivudine/Zidovudine to Explore Metabolic Toxicities in Antiretroviral HIV-Infected SubjectsCompletedNCT00043953Phase 2
• Zidovudine and Lamivudine Given Once Versus Twice DailyCompletedNCT00014014Phase 1
• A Comparison of BMS-232632 With Efavirenz, Each in Combination With Zidovudine-LamivudineCompletedNCT00013897Phase 3
• Safety and Effectiveness of TRIZIVIR (Abacavir/Lamivudine/Zidovudine) With Efavirenz in HIV-Infected Patients Who Have Never Taken Anti-HIV DrugsStatus unknownNCT00011895Phase 4
• Four-Drug Combination Therapy With Zidovudine, Lamivudine, 1592U89 (Abacavir), and 141W94 (Amprenavir) in HIV-Infected PatientsCompletedNCT00006617Not applicable
• Effectiveness of Adding Interleukin-2 to Anti-HIV Drugs in Patients Recently Infected With HIVCompletedNCT00006441Not applicable
• Zidovudine Plus Interleukin-2 and Ganciclovir in Treating Patients With AIDS-Related Primary Central Nervous System LymphomaCompletedNCT00006264Phase 2
• A Comparison of Three Anti-HIV Drug Combinations in HIV-Infected PatientsCompletedNCT00005106Phase 4
• Effectiveness of a New Anti-HIV Drug (AG1549) Plus Viracept (Nelfinavir) Plus Combivir (Zidovudine/Lamivudine) in HIV-Infected PatientsSuspendedNCT00004999Phase 2
• Safety and Effectiveness of Three Anti-HIV Drugs Combined in One Pill (Trizivir)Status unknownNCT00004981Phase 3
• Safety and Effectiveness of Lamivudine When Given Once a Day Versus Twice a Day in Combination With Other Anti-HIV Drugs in HIV-Infected Adults Who Have Never Received Anti-HIV DrugsCompletedNCT00004852Phase 2
• A Study of the Safety and Effectiveness of Combination Anti-HIV Therapy in HIV-Infected AdultsCompletedNCT00004585Phase 4
• Chemotherapy and Radiation Therapy in Treating Patients With HIV-Related Primary Central Nervous System LymphomaStatus unknownNCT00003261Phase 2
• The Safety and Effectiveness of MK-639 and Zidovudine, Used Alone and Together, in HIV-Infected Patients Who Have Never Taken Anti-HIV DrugsCompletedNCT00002443Not applicable
• A Study of Three Different Anti-HIV Drug Combinations in HIV-Infected PatientsCompletedNCT00002410Phase 3
• The Effect of Teaching HIV-Infected Patients About HIV and TreatmentCompletedNCT00002409Phase 3
• A Study of Delavirdine Used Together With Other Anti-HIV Drugs in HIV-Infected PatientsCompletedNCT00002401Not applicable
• A Study of Two Anti-HIV Drug Combinations in HIV-Infected PatientsCompletedNCT00002400Not applicable
• The Safety and Effectiveness of Zidovudine Plus Lamivudine, Used With and Without 1592U89, in HIV-1 Infected Children Who Have Taken Anti-HIV-1 DrugsCompletedNCT00002391Phase 3
• The Safety and Effectiveness of Lamivudine Plus Zidovudine, Used With and Without 1592U89, in HIV-1 Infected Patients Who Have Never Taken Anti-HIV DrugsCompletedNCT00002389Phase 3
• The Safety and Effectiveness of Adefovir Dipivoxil Plus Indinavir Combined With Zidovudine or Lamivudine or Stavudine in HIV-Infected Patients Who Have Not Taken Anti-HIV DrugsCompletedNCT00002379Phase 2
• The Safety and Effectiveness of Lamivudine Plus Stavudine or Zidovudine in HIV-Infected Patients Who Have Taken ZidovudineCompletedNCT00002371Phase 3
• A Study of Saquinavir Soft Gelatin Capsules Plus Zidovudine Plus Lamivudine in the Treatment of HIV-1 Infected Patients Who Have Never Taken Anti-HIV DrugsCompletedNCT00002367Phase 3
• A Study of Zidovudine (AZT) Used Alone or in Combination With Other Anti-HIV Drugs in HIV-Infected Patients With Little or No Previous TreatmentCompletedNCT00002334Phase 3
• The Safety and Effectiveness of Zidovudine Plus Adefovir in HIV-Infected PatientsCompletedNCT00002326Phase 1
• The Safety and Effectiveness of Nevirapine and Zidovudine, Given Separately and Together, in HIV-1 Infected Patients Who Have No Symptoms of the DiseaseCompletedNCT00002324Phase 2
• A Multi-Center, Placebo-Controlled, Double-Blind, Randomized Trial Comparing the Virologic and Immunologic Activities of 400 Mg Nevirapine in Combination With Zidovudine Versus Zidovudine Alone in Asymptomatic HIV-1 Infected Patients With 4-12 Months of Prior Zidovudine Therapy and 200-500 CD4+ CellCompletedNCT00002323Not applicable
• A Study of Different Doses of Atevirdine Mesylate Plus Zidovudine in HIV-Positive PatientsCompletedNCT00002322Phase 2
• A Comparison of Lamivudine and Zidovudine, Used Alone and Together, in HIV-Infected Patients Who Have Not Used Zidovudine in the PastCompletedNCT00002320Phase 3
• The Safety and Effectiveness of U-90152 in HIV-1 Infected Patients Who Take ZidovudineCompletedNCT00002312Not applicable
• A Comparison of Zidovudine (AZT) and Stavudine in HIV-Infected PatientsCompletedNCT00002307Not applicable
• The Safety and Effectiveness of Zidovudine Plus Acyclovir in Patients With Early HIV InfectionCompletedNCT00002290Not applicable
• The Safety and Effectiveness of Retrovir in HIV-Infected Patients Who Have Problems Related to the Nervous SystemCompletedNCT00002288Not applicable
• A Study of Retrovir in the Prevention of HIV Infection in Health Care Workers Accidentally Exposed to the VirusCompletedNCT00002287Not applicable
• A Study of Retrovir in the Treatment of Psoriasis in HIV-Positive PatientsCompletedNCT00002286Not applicable
• A Study of Zidovudine and T Lymphocyte Transfer in the Treatment of HIV Type III in Patients With AIDSCompletedNCT00002285Not applicable
• A Study of Azidothymidine (AZT) in the Treatment of HIV Infection in Patients Receiving a Bone Marrow TransplantCompletedNCT00002284Not applicable
• A Study of Granulocyte Colony-Stimulating Factor Plus Recombinant Erythropoietin Plus Zidovudine in Patients With AIDS or AIDS-Related ComplexCompletedNCT00002281Not applicable
• A Pilot Study of the Efficacy of Recombinant Alpha Interferon (IFN-A2b) and Zidovudine (AZT) in the Treatment of Progressive Multifocal Leukoencephalopathy (PML) Complicating HIV-1 InfectionCompletedNCT00002270Not applicable
• An Open-Label Phase I/II Study of Recombinant Granulocyte Colony Stimulating Factor (r-metHuG-CSF) and Recombinant Erythropoietin (rHuEPO) Given Subcutaneously Along With Zidovudine (AZT) to Patients With the Acquired Immune Deficiency Syndrome (AIDS) or Severe AIDS-Related Complex (ARC)CompletedNCT00002255Phase 1
• A Study to Find the Best Dosing Schedule for Delavirdine, Zidovudine, and Indinavir in HIV-Positive PatientsCompletedNCT00002236Not applicable
• A Multicenter, Open-Label, Randomized, 24-Week Study to Compare the Safety and Activity of Indinavir Sulfate, 800 Mg q 8 h Versus 1,200 Mg q 12 h in Combination With Zidovudine and 3TCCompletedNCT00002208Phase 3
• A Phase II Open-Label Exploratory Study of Saquinavir + Zidovudine + Lamivudine in HIV Infected PatientsCompletedNCT00002190Phase 2
• The Effectiveness of Indinavir Plus Zidovudine Plus Lamivudine in HIV-Infected Patients With No Symptoms of InfectionCompletedNCT00002179Phase 4
• A Six-Month Safety and Antiviral Study in HIV-1 Seropositive, AZT-Experienced Patients With CD4 Counts Less Than or Equal to 50 Cells/mm3 to Evaluate MK-639 Alone Versus Zidovudine (AZT) and 3TC Versus the Combination of MK-639 With AZT/3TCCompletedNCT00002155Not applicable
• A Double-Blind, Randomized, Dose Response Study of Three Doses of Delavirdine Mesylate (U-90152S) in Combination With Zidovudine (ZDV) Versus ZDV Alone in HIV-1 Infected Individuals With CD4 Counts of 200-500mm3CompletedNCT00002124Phase 3

← Zidovudine overview